Tag: drug development
Faro banks $37.3M to put AI agents inside clinical trials
Agentic AI platform for clinical development closes a $37.3M Series B led by Merck's health fund and S32.
Startup keeps donated skin alive to train its biology AI
Outer Biosciences sustains surgically discarded tissue for a month to build better models.
TCS launches agentic AI hub for clinical trials and drug safety
TCS launches an agentic AI hub that brings governed agents to clinical trials and drug safety work.
Tufts study prices agentic AI monitoring at $21M per trial program
A Tufts CSDD analysis values Medable's AI clinical monitoring agent at up to $21M per drug program with 82x ROI…
Anthropic’s Claude takes on trial enrollment delays in ICON pact
CRO giant ICON will weave Anthropic's Claude into site selection, feasibility and enrollment monitoring across its agentic Orbis platform.
QuantHealth banks $45M to simulate trials before enrollment
Israeli startup QuantHealth raises $45M to scale AI-powered clinical trial simulations.
AstraZeneca taps AI to de-risk late-stage trials and speed up filings
AstraZeneca CEO Pascal Soriot said the company is using AI to de-risk late-stage clinical trials and accelerate regulatory submissions.
Over 173 AI-designed drugs now in trials as FDA decision nears
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…